Add-on Therapy Improves Outcomes in Severe Asthma – Medscape

Add-on Therapy Improves Outcomes in Severe Asthma
Medscape
May 5, 2011 — Omalizumab may provide additional relief for patients with severe allergic asthma who do not respond adequately to inhaled corticosteroids (ICS) or long-acting beta 2 -agonists (LABAs), investigators report in the May 3 issue of the

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *